Skip to search.
 Dow Down 0.60% Nasdaq Down 0.07%

More On PLMO.PK

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Pulmo BioTech Inc. (PLMO.PK)

-OTC Markets

0.02 Up 0.00(14.29%) May 25, 10:36AM EDT

ProfileGet Profile for:
Pulmo BioTech Inc.
1035 Park Avenue
Suite 7B
New York, NY 10028-0912
United States - Map
Phone: 646-827-9362
Fax: 646-827-5432
Website: http://www.pulmobiotech.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Pulmo Bio Tech Inc., through its subsidiary, PulmoScience, Inc., engages in developing a non-invasive molecular imaging technique for the diagnosis of pulmonary embolism, pulmonary hypertension, and lung inflammatory diseases under the trade name PulmoBind. The PulmoBind uses an intravenously delivered radionuclide tagged molecule, which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. It is under the regulatory approval process for Phase I human trials. The company was founded in 2006 and is based in New York, New York.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Pulmo BioTech Inc.

Key Executives 
 PayExercised
Mr. Garry McCann , 52
Chief Exec. Officer, Pres, Treasurer and Director
N/AN/A
Mr. Rajiv Garg , 53
Chief Financial Officer
N/AN/A
Mr. Peter B. Hirshfield Esq., 65
Sec.
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.